Get the Stockscreener App
34.73
2.36%
0.785
Veracyte Inc stock is traded at $34.73, with a volume of 411.18K.
It is up +2.36% in the last 24 hours and up +9.04% over the past month.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
See More
Previous Close:
$33.95
Open:
$34.2
24h Volume:
411.18K
Relative Volume:
0.30
Market Cap:
$2.73B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-46.31
EPS:
-0.75
Net Cash Flow:
$40.13M
1W Performance:
-1.00%
1M Performance:
+9.04%
6M Performance:
+9.41%
1Y Performance:
+2.00%
1-Day Range:
$33.98
$35.38
1-Week Range:
$33.20
$35.66
52-Week Range:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
34.74 | 2.67B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
528.29 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
207.20 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
639.38 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
139.13 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
204.44 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Initiated | Craig Hallum | Buy |
| Dec-05-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Can Veracyte Inc. stock beat market expectations this quarterMarket Volume Summary & Free Technical Pattern Based Buy Signals - newser.com
How Veracyte Inc. stock performs in interest rate cyclesBuy Signal & Momentum Based Trading Signals - newser.com
Will Veracyte Inc. benefit from macro trendsWeekly Stock Report & Short-Term High Return Ideas - newser.com
Is Veracyte Inc. stock bottoming out2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Will Veracyte Inc. stock benefit from commodity pricesVolume Spike & Reliable Entry Point Alerts - newser.com
Building trade automation scripts for Veracyte Inc.Stock Surge & Safe Capital Allocation Plans - newser.com
Will Veracyte Inc. stock remain a Wall Street favorite2025 AllTime Highs & Daily Volume Surge Signals - newser.com
Key resistance and support levels for Veracyte Inc.July 2025 Earnings & Long-Term Safe Return Strategies - newser.com
What analyst consensus implies for Veracyte Inc. (12V) stockRate Hike & Technical Confirmation Trade Alerts - newser.com
Veracyte, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Veracyte (VCYT): Assessing Valuation After BALANCE Trial Data and Analyst Upgrades Boost Investor Confidence - Sahm
How high can Veracyte Inc. stock goInsider Buying & Stock Portfolio Risk Control - newser.com
Veracyte Inc. stock daily chart insights2025 Earnings Impact & Real-Time Volume Analysis Alerts - newser.com
Veracyte Inc Stock Analysis and ForecastPrice Volatility Patterns & Rapid Capital Growth - earlytimes.in
What MACD signals say about Veracyte Inc.Trade Analysis Summary & AI Enhanced Market Trend Forecasts - newser.com
Real time social sentiment graph for Veracyte Inc.Layoff News & Daily Volume Surge Trade Alerts - newser.com
Has Veracyte Inc. formed a bullish divergenceJuly 2025 Summary & Real-Time Volume Triggers - newser.com
Why Veracyte Inc. (12V) stock stays on buy listsJuly 2025 Setups & Safe Capital Growth Stock Tips - newser.com
Veracyte's (VCYT) Sell (D+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Does Veracyte Inc. qualify in momentum factor screeningJuly 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com
How supply chain issues affect Veracyte Inc. stockJuly 2025 Recap & Fast Gain Swing Alerts - newser.com
Veracyte (NASDAQ:VCYT) Upgraded to "Strong-Buy" at Zacks Research - MarketBeat
What analysts say about Veracyte Inc 12V stockStock Price Targets & Superior Capital Trading Plans - earlytimes.in
Insider Sell: Phillip Febbo Sells Shares of Veracyte Inc (VCYT) - GuruFocus
Veracyte (NASDAQ:VCYT) Insider Sells 8,349 Shares - MarketBeat
Is Veracyte Inc a good long term investmentStock Price Forecasts & Options Trading Analysis Tools - earlytimes.in
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar - Yahoo Finance
Veracyte, Inc. (VCYT) Stock Analysis: 11.33% Potential Upside Amid Robust Diagnostic Innovations - DirectorsTalk Interviews
Will Veracyte (VCYT) Leverage PAM50 Data to Strengthen Its Position in Precision Oncology? - Sahm
Veracyte (VCYT): Reassessing Valuation After New BALANCE Trial Data Highlights Decipher’s Clinical Impact - Yahoo Finance
If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Why Veracyte Inc. (12V) stock could break out in 2025Weekly Trade Review & Reliable Trade Execution Plans - newser.com
Using data tools to time your Veracyte Inc. exitWeekly Trend Summary & Safe Entry Trade Signal Reports - newser.com
How Veracyte Inc. (12V) stock compares with top peersEarnings Recap Report & Low Risk Entry Point Tips - newser.com
Can machine learning forecast Veracyte Inc. recoveryQuarterly Market Summary & Precise Trade Entry Recommendations - newser.com
Veracyte to replace Triumph in S&P SmallCap 600 index - MSN
Insider Sell Alert: John Leite Sells Shares of Veracyte Inc (VCY - GuruFocus
Veracyte started at buy by UBS, MRD platform cited - MSN
Veracyte Inc. stock outlook for YEAR2025 Bull vs Bear & Momentum Based Trading Signals - newser.com
Applying sector rotation models to Veracyte Inc.Portfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
AMI Asset Management Corp Sells 8,580 Shares of Veracyte, Inc. $VCYT - MarketBeat
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.21%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):